Back to All Events

Use of Methylation to Change Brain Tumor Management

  • Toronto Western Hospital 399 Bathurst Street Toronto, ON, M5T 2S6 Canada (map)

Presenter: Dr. Gelareh Zadeh

Biography: Dr. Gelareh Zadeh, MD, PhD, FRCS(C), FAANS, is Dan Family Chair and Professor of

Neurosurgery, University of Toronto. She is Head of the Department of Neurosurgery at

Toronto Western Hospital and Medical Director for the Krembil Brain Institute at

University Health Network. Dr. Zadeh is a Senior Scientist at Princess Margaret Cancer

Centre where she runs a translational research program at MacFeeters-Hamilton Neuro-

oncology Program and holds the Wilkins Family Brain Tumor Research Chair.

Dr. Zadeh has a dedicated neuro-oncology and skull base practice, which includes a number

of multidisciplinary specialized programs including a skull base clinic, brain metastases,

pituitary clinic, and neurofibromatosis clinics. In parallel, she has an active research

laboratory focusing on integrated multi-platform molecular analysis of brain tumors,

together with a focus on understanding molecular response to targeted therapies, such as

anti-angiogenesis and metabolic inhibitors. She is also involved in a number of national and

international organizations. She is President of Society of Neuro-Oncology (SNO), and the

past Chair of Neuro-oncology Committee at the World Federation of Neurological Surgeons,

she is the Co-Chair and founder of the International Consortium on Meningiomas (ICOM).

She is the Editor-in-Chief of Neuro-Oncology Advances, open access journal of SNO and

EANO.